A Personalized Starting Point
Discuss your pregnancy goals, cycle patterns, prior pregnancies, medications, surgeries, and relevant family history. Testing is selected for a clinical reason rather than ordered as one universal panel.
Clear answers about reproductive health, hormone testing, and your next steps toward family planning.
Book Your AppointmentWhether you are planning ahead or having difficulty conceiving, a consultation can help identify which evaluations fit your needs. Fertility assessment combines medical history, relevant testing, and guidance—not a single fertility score.

Discuss your pregnancy goals, cycle patterns, prior pregnancies, medications, surgeries, and relevant family history. Testing is selected for a clinical reason rather than ordered as one universal panel.
Results help guide next steps, but normal hormone levels do not guarantee conception. A complete assessment may also require semen analysis, imaging, or specialist care.
You do not have to wait to ask questions about family planning. The timing of an infertility evaluation depends on age, history, and how long you have been trying.
Evaluation is generally recommended after 12 months of regular unprotected intercourse without pregnancy.
Seek evaluation after 6 months without pregnancy. Over age 40, a more immediate assessment may be appropriate.
Irregular or absent periods, known reproductive conditions, prior chemotherapy, or suspected male-factor concerns can justify earlier evaluation.
A preconception visit can review medications, health conditions, and future goals. Routine ovarian-reserve screening is not recommended as a general fertility test for people without infertility.
When applicable, both partners should be evaluated in parallel. Your provider can explain what each test contributes and what it cannot tell you.

Depending on your history, evaluation may include AMH, appropriately timed FSH and estradiol, or progesterone to assess recent ovulation. Thyroid or prolactin testing is selected when indicated.
Semen analysis evaluates sperm concentration, movement, and shape. Hormone tests may be useful when symptoms or semen findings suggest an endocrine contributor. An abnormal semen result may need confirmation.
Useful testing answers a specific question. Your age, medical history, and the overall evaluation remain important.
AMH and related measures can help estimate ovarian response to stimulation. They do not directly measure egg quality, provide an exact egg count, or reliably predict natural pregnancy on their own.
Some hormone levels change across the menstrual cycle. Follow the timing instructions for your particular test; progesterone testing is not automatically scheduled for day 21 in every cycle.
Carrier screening addresses the chance of passing on certain inherited conditions. It does not measure fertility. Chromosomal testing is reserved for specific indications and may require genetic counseling.
Hormone panels cannot assess every cause of infertility. Ultrasound, evaluation of the fallopian tubes, or reproductive-urology assessment may be needed through a specialist.
Tell your prescriber if you want children now or in the future. This conversation is best started before beginning testosterone therapy.
Testosterone can suppress sperm production. Testosterone monotherapy should not be prescribed to men pursuing current or future fertility. Do not change treatment on your own; review your goals with your clinician or a reproductive urologist.
Depending on the diagnosis, specialists may consider fertility-focused treatment or sperm banking. Selected medications, including hCG or off-label clomiphene, may be appropriate in some cases; they are not interchangeable or suitable for everyone.
Recovery of sperm production can take time and is not guaranteed. Semen testing and specialist guidance are more informative than testosterone levels alone when assessing reproductive potential.
Our Pasadena team can help you understand the findings and coordinate appropriate next steps.

Bring prior lab results, a medication and supplement list, and relevant cycle or fertility history.
Review test timing, collection instructions, expected turnaround, and costs before proceeding. At-home semen collection may be an option when supported by the laboratory protocol.
Discuss findings in plain language, including limitations and whether additional evaluation would change care.
Referral may be appropriate for reproductive endocrinology, reproductive urology, genetic counseling, or fertility preservation. A consultation does not promise pregnancy or replace a full infertility evaluation.
Practical answers before your visit.
No. AMH is a marker used in ovarian-reserve assessment, especially to anticipate response to ovarian stimulation. It does not directly measure egg quality or guarantee future pregnancy.
When a couple is being evaluated for infertility, parallel evaluation is generally appropriate. The plan depends on each person’s reproductive role and history.
Sometimes. The laboratory must provide collection, handling, and transport instructions. Home screening products vary and may not provide a complete semen analysis.
Yes, but TRT can markedly suppress sperm production. Discuss a fertility-focused plan with the prescriber and, when appropriate, a reproductive urologist. Recovery and outcomes vary.
No. Testing should reflect your symptoms, history, and clinical question. More tests do not automatically provide better answers.
Coverage varies by plan, indication, and laboratory. Confirm benefits and expected out-of-pocket costs before testing.
A consultation may be available by telehealth where the provider is licensed. Blood collection, examination, imaging, or specialist procedures may require in-person care.
Turnaround depends on the test and laboratory. Your team can explain the expected timing and arrange a review once results are available.
Discuss your reproductive goals and the evaluation that makes sense for you.
Book Your Appointment